NELSON SANTANA: Open Payments
NPI 1346754561 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,597 in 73 payments from 15 companies in 2025. Trend: 2023 $134 · 2024 $1,145 · 2025 $1,597
Food & beverage: $1,597
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $313 |
| Ipsen Biopharmaceuticals, Inc | 9 | $248 |
| Madrigal Pharmaceuticals | 4 | $218 |
| Intercept Pharmaceuticals, Inc. | 6 | $165 |
| Janssen Biotech, Inc. | 9 | $156 |
| Ardelyx, Inc. | 8 | $144 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $107 |
| Aimmune Therapeutics, Inc. | 4 | $67 |
| Phathom Pharmaceuticals, Inc. | 3 | $44 |
| Novo Nordisk Inc | 2 | $38 |
Products named: IQIRVO, REZDIFFRA, OCALIVA, TREMFYA, IBSRELA, LINZESS, EOHILIA, RINVOQ.
Industry payments across FL — which companies pay providers there.
